SEARCH

SEARCH BY CITATION

References

  • 1
    Lebron GM, Herrera Gutierrez ME, Seller PG, Curiel BE, Fernandez Ortega JF, Quesada GG. Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transplant 2004; 10: 13791385.
  • 2
    Chuang FR, Lin CC, Wang PH et al. Acute renal failure after cadaveric related liver transplantation. Transplant Proc 2004; 36: 23282330.
  • 3
    Narayanan Menon KV, Nyberg SL, Harmsen WS et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004; 4: 819825.
  • 4
    Gainza FJ, Valdivieso A, Quintanilla N et al. Evaluation of acute renal failure in the liver transplantation perioperative period: Incidence and impact. Transplant Proc 2002; 34: 250251.
  • 5
    Brown RS, Jr., Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996; 62: 17881793.
  • 6
    Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998; 54: 518524.
  • 7
    Gonwa TA, Mai ML, Melton LB et al. Renal replacement therapy and orthotopic liver transplantation: The role of continuous veno-venous hemodialysis. Transplantation 2001; 71: 14241428.
  • 8
    Bugge JF. Influence of renal replacement therapy on pharmacokinetics in critically ill patients. Best Pract Res Clin Anaesthesiol 2004; 18: 175187.
  • 9
    Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Immune system dysregulation in uremia. Semin Nephrol 1994; 14: 253260.
  • 10
    Jubelirer SJ. Hemostatic abnormalities in renal disease. Am J Kidney Dis 1985; 5: 219225.
  • 11
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818829.
  • 12
    Alvares-Da-Silva MR, Waechter FL, Francisconi CF et al. Risk factors for postoperative acute renal failure at a new orthotopic liver transplantation program. Transplant Proc 1999; 31: 30503052.
  • 13
    Rimola A, Gavaler JS, Schade RR, El Lankany S, Starzl TE, Van Thiel DH. Effects of renal impairment on liver transplantation. Gastroenterology 1987; 93: 148156.
  • 14
    Cabezuelo JB, Ramirez P, Acosta F et al. Prognostic factors of early acute renal failure in liver transplantation. Transplant Proc 2002; 34: 254255.
  • 15
    Bilbao I, Charco R, Balsells J et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998; 12: 123129.
  • 16
    Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204R212.
  • 17
    Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling CR. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005; 20: 354360.
  • 18
    Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10: R73.
  • 19
    Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 2006; 81: 542546.
  • 20
    Guitard J, Cointault O, Kamar N et al. Acute renal failure following liver transplantation with induction therapy. Clin Nephrol 2006; 65: 103112.
  • 21
    Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM. The outcome of acute renal failure in the intensive care unit according to RIFLE: Model application, sensitivity, and predictability. Am J Kidney Dis 2005; 46: 10381048.
  • 22
    Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 19131917.
  • 23
    Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 31603167.
  • 24
    Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 25602572.
  • 25
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461470.
  • 26
    Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 27
    Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328338.
  • 28
    Davenport A, Finn R, Goldsmith HJ. Management of patients with renal failure complicated by cerebral oedema. Blood Purif 1989; 7: 203209.
  • 29
    Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 1993; 41: S245S251.
  • 30
    Sanchez EQ, Gonwa TA, Levy MF et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004; 78: 10481054.
  • 31
    Lima EQ, Zanetta DM, Castro I et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail 2003; 25: 553560.
  • 32
    Contreras G, Garces G, Quartin AA et al. An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation. J Am Soc Nephrol 2002; 13: 228233.
  • 33
    Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352357.
  • 34
    Hampel H, Bynum GD, Zamora E, El Serag HB. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol. 2001; 96: 22062210.
    Direct Link:
  • 35
    Desai TK, Tsang TK. Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 1988; 85: 4750.
  • 36
    Gayowski T, Singh N, Keyes L et al. Late-onset renal failure after liver transplantation: Role of posttransplant alcohol use. Transplantation. 2000; 69: 383388.
  • 37
    Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med 1997; 126: 275279.
  • 38
    Falagas ME, Arbo M, Ruthazer R et al. Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients. Transplantation 1997; 63: 15951601.
  • 39
    Wiesner RH, Demetris AJ, Belle SH et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638645.
  • 40
    Thuluvath PJ. When is diabetes mellitus a relative or absolute contraindication to liver transplantation? Liver Transplant 2005; 11: S25S29.
  • 41
    Trail KC, Stratta RJ, Larsen JL et al. Results of liver transplantation in diabetic recipients. Surgery 1993; 114: 650656.
  • 42
    Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 10071012.